Literature DB >> 9207376

Viral interleukin-10 in chronic active Epstein-Barr virus infection.

H Kanegane1, H Wakiguchi, C Kanegane, T Kurashige, G Tosato.   

Abstract

Viral interleukin-10 (IL-10), a product of the Epstein-Barr virus (EBV) replication gene BCRF1, shares extensive structural and functional similarity with the human cytokine IL-10. Both viral and human IL-10 inhibit T cell growth and interferon-gamma production. With two ELISAs, one that recognized both human and viral (total) IL-10 and the other specific for viral IL-10, IL-10 was measured in serum or plasma from 34 patients with chronic active EBV infection (CAEBV) and from 15 healthy controls. Of the patients, 56% had measurable total IL-10 and 29% had measurable viral IL-10. In contrast, total IL-10 was detectable in only 2 of 15 controls and viral IL-10 was undetectable. Thus, many patients with CAEBV have abnormally high levels of circulating IL-10 that may contribute to disease pathogenesis by inhibiting host immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207376     DOI: 10.1086/517260

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation.

Authors:  L Faulkner; G Buchan; M Baird
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

Review 2.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

3.  Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.

Authors:  Keiko Nomura; Hirokazu Kanegane; Keisuke Otsubo; Hiroshi Wakiguchi; Yukihiro Noda; Yoshihito Kasahara; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2011-05-28       Impact factor: 2.490

4.  Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis.

Authors:  J W Peacock; K L Bost
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

Review 5.  Hodgkin disease and the role of the immune system.

Authors:  Alana A Kennedy-Nasser; Patrick Hanley; Catherine M Bollard
Journal:  Pediatr Hematol Oncol       Date:  2011-04       Impact factor: 1.969

6.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

Review 7.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.

Authors:  Q Zhang; X D Zhou; T Denny; J E Ottenweller; G Lange; J J LaManca; M H Lavietes; C Pollet; W C Gause; B H Natelson
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

Review 9.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

10.  Identification of EBV infection in adults with egg specific food allergy.

Authors:  Yang Pan; Zhiyang Nie; Yuan Zhang; Kuo Zhang; Jinming Li; Lunan Wang
Journal:  Virol J       Date:  2013-01-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.